New and Events
HUNTSVILLE, Alabama - November 5, 2010 — Cocoon Resources, Inc., a venture group focused in biotech, pharma, and energy, announced today that it was successful in gaining a grant for Volatile Analysis Corp., currently an incubator resident. Volatile Analysis was awarded $206,000.00 by the United States government (IRS, HHS, NIH) under the Qualifying Therapeutic Discovery Project (QTDP) program. Grants were awarded based on project merit to create and sustain high-quality, high-paying U.S. jobs that advance U.S. competitiveness in life, biological and medical sciences. The grant acknowledges Volatile Analysis’ work with patent pending sorptive nasal stent technology in disease and chemical detection.
The grant will aid in further development of a device that facilitates biomarker detection indicative of disease states. The patent pending sorptive nasal stent extracts trace levels of volatile and semi-volatile metabolites produced in the body that are indicative of disease states with potential for early detection of cancer and infectious diseases. Primary inventor Dr. Russell Bazemore said “Volatile Analysis’ sorptive nasal stent will work with standard gas chromatography thereby making the field of breath metabolomics available to a greater number of researchers. This will also enable a greater number of therapies to be screened.”
"This grant will bring a much faster track for the development of Volatile Analysis’ patent pending breath metabolomics technologies for disease and chemical detection," said Katherine Malmay-Bazemore, Cocoon Resources CEO, and Co-founder of Volatile Analysis. “We are extremely pleased to be awarded this grant because it acknowledges Volatile Analysis’ breath metabolomics expertise and technology.”
Click here for a pdf download.
About Volatile Analysis Corporation:
Since February, 2007 Volatile Analysis (http://www.volatileanalysis.com) has worked to create technologies and resolve problems associated with volatile and semi-volatile compounds in the areas of:
• extraction and identification of volatiles and semi-volatiles from the breath and oral cavity
• correlation of breath volatiles with disease states (metabolomics)
• drug detection
• off- odors in foods/ beverages/ cosmetics/ packaging
• scent technology
• novel sample prep/ extraction
• trace level quantification
Volatile Analysis Corporation collaborates and provides services for:
• Universities:
o Partner for technology transfer and commercialization of university inventions
o Hands on GC/MS and GC-MS/O equipment training for faculty/ students
• Industry:
o Outsource laboratory needs including Research and Development (R&D), Quality Analysis (QA), risk mitigation services through testing and analysis including sophisticated aroma analysis.
• Government:
o Testing services and trace level analysis
